Treatment Planning Process Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Treatment Planning Process. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Treatment Planning Process Indian Medical PG Question 1: Which of the following stages of Breast Cancer corresponds to the following features: a breast mass of 6 x 3 cm, ipsilateral supraclavicular lymph node involvement, and distant metastasis that cannot be assessed?
- A. T4 N3 MX
- B. T4 N1 M1
- C. T4 N0 M0
- D. T3 N3c MX (Correct Answer)
Treatment Planning Process Explanation: ***T3 N3c MX***
- A **breast mass of 6 x 3 cm** indicates a T3 tumor (tumor size > 5 cm).
- **Ipsilateral supraclavicular lymph node involvement** is classified as N3c disease. **Distant metastasis that cannot be assessed** is denoted by MX.
*T4 N3 MX*
- A **T4 classification** is reserved for tumors with direct extension to the chest wall or skin, or inflammatory breast cancer, which is not mentioned here.
- While N3c and MX are correct for the nodal and metastatic status, the T stage is inaccurate based on the provided tumor size.
*T4 N1 M1*
- A **T4 classification** is incorrect as the mass size alone (6 x 3 cm) does not meet T4 criteria.
- **N1** denotes involvement of 1-3 axillary lymph nodes, which is less extensive than supraclavicular involvement (N3c). **M1** indicates confirmed distant metastasis, but the question states it "cannot be assessed" (MX).
*T4 N0 M0*
- **T4** is incorrect, as this stage is for direct chest wall/skin involvement or inflammatory breast cancer.
- **N0** signifies no regional lymph node metastasis, contradicting the presence of supraclavicular lymph node involvement. **M0** indicates no distant metastasis, whereas the question specifies it cannot be assessed (MX).
Treatment Planning Process Indian Medical PG Question 2: Which phase of the cell cycle is most sensitive to radiotherapy?
- A. M phase (Correct Answer)
- B. G1 phase
- C. S phase
- D. G2 phase
Treatment Planning Process Explanation: ***M phase***
- Cells in the **M phase** (mitosis) are generally the most sensitive to radiation-induced damage due to their condensed chromosomes and active processes of chromosome segregation [2].
- DNA in the M phase is highly accessible and vulnerable to breaks, making it difficult for the cell to repair damage before division.
*G1 phase*
- The **G1 phase** is relatively radioresistant because the cell has ample time to repair DNA damage before DNA replication [1].
- Cells are actively growing and performing normal functions, with chromosomes in a decondensed state.
*S phase*
- The **S phase**, during which DNA synthesis occurs, is intermediate in terms of radiosensitivity.
- While DNA is being replicated, there are active repair mechanisms, making it more resistant than M phase but less than G1.
*G2 phase*
- The **G2 phase** is generally considered the second most radiosensitive phase, as DNA has been replicated but the cell is preparing for mitosis and has less time for repair before division.
- Radiation damage during G2 can disrupt the fidelity of chromosome distribution in the upcoming M phase.
**References:**
[1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 302-303.
[2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 112-113.
Treatment Planning Process Indian Medical PG Question 3: Radiation exposure can lead to which type of thyroid carcinoma?
- A. Lymphoma
- B. Papillary carcinoma (Correct Answer)
- C. Medullary carcinoma
- D. Follicular carcinoma
Treatment Planning Process Explanation: ***Papillary carcinoma***
- Papillary thyroid carcinoma is strongly associated with **radiation exposure**, particularly during childhood [1].
- It is the most prevalent type of thyroid cancer and typically has a **good prognosis** [1].
*Lymphoma*
- Thyroid lymphoma is rare and generally not linked to **radiation exposure**; it often presents as a **rapidly enlarging goiter**.
- It is more commonly associated with **autoimmune thyroiditis**, not primary radiation effects.
*Follicular carcinoma*
- Follicular carcinoma shows a correlation with **iodine deficiency** rather than radiation exposure [1].
- Its presentation is more subtle, compared to the classical association of **radiation with papillary carcinoma**.
*Medullary carcinoma*
- Medullary thyroid carcinoma is primarily linked to **familial syndromes** like MEN 2 and not radiation exposure.
- It arises from **parafollicular C cells**, making it clinically distinct from radiation-related types.
**References:**
[1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1098-1099.
Treatment Planning Process Indian Medical PG Question 4: Which finding excludes BIRADS 3 categorization?
- A. Normal lymph node
- B. Simple cyst
- C. Architectural distortion (Correct Answer)
- D. Focal asymmetry
Treatment Planning Process Explanation: ***Architectural distortion***
- **Architectural distortion** refers to a disruption of the normal breast parenchymal architecture in the absence of a discrete mass, often indicating an underlying malignancy.
- This finding is suspicious enough to warrant a recommendation of **biopsy (BI-RADS 4 or 5)**, thus **excluding BI-RADS 3**, which implies a probably benign finding with a low likelihood of malignancy (<2%).
- Architectural distortion has a high association with malignancy and cannot be categorized as BI-RADS 3.
*Normal lymph node*
- A **normal lymph node** within the breast or axilla is a common and benign finding, characterized by an oval shape, fatty hilum, and thin cortex.
- Its presence does not increase the suspicion of malignancy and is classified as **BI-RADS 1 or 2** (definitely benign).
- This does NOT exclude BI-RADS 3; it is simply a more benign finding.
*Simple cyst*
- A **simple cyst** is a very common and benign fluid-filled sac, readily identifiable by clear sonographic criteria (anechoic, thin smooth walls, posterior acoustic enhancement).
- It is classified as **BI-RADS 2** (benign finding), meaning it is definitely not malignant.
- This does NOT exclude BI-RADS 3; it is simply a more benign finding that does not require follow-up.
*Focal asymmetry*
- **Focal asymmetry** refers to an area of fibroglandular tissue that is visible on only one mammographic projection or is less conspicuous than a mass.
- If it has **no associated suspicious features**, it can be appropriately categorized as **BI-RADS 3**, requiring short interval follow-up.
- This does NOT exclude BI-RADS 3 categorization.
Treatment Planning Process Indian Medical PG Question 5: Which of the following statements accurately describes the relationship between quality assurance (QA), quality control (QC), internal quality assurance (IQA), and external quality assurance (EQA)?
- A. Quality Control (QC) is a process that supports Quality Assurance (QA).
- B. Quality Control (QC) and Quality Assurance (QA) are distinct but interrelated processes.
- C. Quality Assurance (QA) focuses solely on compliance and excludes Quality Control (QC).
- D. Quality Assurance (QA) includes Quality Control (QC), Internal Quality Assurance (IQA), and External Quality Assurance (EQA). (Correct Answer)
Treatment Planning Process Explanation: ***Quality Assurance (QA) includes Quality Control (QC), Internal Quality Assurance (IQA), and External Quality Assurance (EQA).***
- **Quality Assurance (QA)** is the comprehensive, overarching system that encompasses all systematic activities designed to ensure quality throughout the entire process—from planning and design to implementation and evaluation.
- **Quality Control (QC)** is an integral component within QA that focuses on operational techniques and activities used to fulfill quality requirements and detect defects in the final product or service.
- **Internal Quality Assurance (IQA)** refers to quality assessment activities conducted within the organization itself (self-assessment, internal audits).
- **External Quality Assurance (EQA)** involves quality assessment by external agencies (proficiency testing, external audits, accreditation).
- All three (QC, IQA, EQA) function as **components within the broader QA framework**, making this the most comprehensive and accurate description of their relationship.
*Quality Control (QC) is a process that supports Quality Assurance (QA).*
- While this statement is true, it is incomplete and understates the relationship.
- QC is not merely "supportive" but is an **integral operational component** embedded within the QA system.
- This option fails to capture the comprehensive hierarchical relationship where QA serves as the umbrella framework encompassing QC, IQA, and EQA.
*Quality Control (QC) and Quality Assurance (QA) are distinct but interrelated processes.*
- From an operational perspective, QA (proactive, prevention-focused) and QC (reactive, detection-focused) do have distinct roles.
- However, in quality management frameworks, QC is best understood as a **functional component within the broader QA system** rather than as a separate parallel process.
- This option is less precise than the correct answer, which explicitly describes the inclusive hierarchical relationship.
*Quality Assurance (QA) focuses solely on compliance and excludes Quality Control (QC).*
- This statement is factually incorrect on both counts.
- **QA is not limited to compliance**; it encompasses proactive planning, continuous improvement, systematic monitoring, and excellence in all processes—far beyond mere regulatory compliance.
- **QA explicitly includes QC** as a core operational function for monitoring and verifying the quality of outputs, making the claim of exclusion completely wrong.
Treatment Planning Process Indian Medical PG Question 6: Gold standard investigation for breast carcinoma screening in a patient with silicone breast implants
- A. Mammography
- B. CT scan
- C. USG
- D. MRI (Correct Answer)
Treatment Planning Process Explanation: ***MRI***
- **MRI** is considered the **gold standard** for breast cancer screening in patients with silicone breast implants due to its superior ability to visualize breast tissue through the implant and detect subtle lesions.
- It offers **high sensitivity** in detecting both implant rupture and early malignancies, often providing better clarity than mammography in augmented breasts where implants can obscure tissue.
*Mammography*
- While a standard screening tool, **mammography** can be limited in patients with silicone implants because the implants can **obscure adjacent breast tissue**, making detection of small masses challenging.
- Special views (e.g., **Eklund views**) can be used, but sensitivity is still reduced compared to MRI in augmented breasts.
*CT scan*
- **CT scans** are not routinely used for primary breast cancer screening due to their use of **ionizing radiation** and lower sensitivity for detecting early breast lesions compared to MRI.
- CT is more commonly used for **staging** advanced cancers or evaluating complex masses detected by other modalities.
*USG*
- **Ultrasound (USG)** is a valuable complementary tool, especially for evaluating palpable lumps or clarifying findings from mammography, but it is **operator-dependent** and has a lower overall sensitivity for general screening compared to MRI.
- It is particularly useful for differentiating between **cystic and solid masses** and detecting implant ruptures but is not the gold standard for comprehensive screening in augmented breasts.
Treatment Planning Process Indian Medical PG Question 7: What are the first-line disease-modifying treatments for Guillain-Barre Syndrome (GBS) in a child?
- A. Intravenous Immunoglobulin (IV Ig) and Plasmapheresis (Correct Answer)
- B. Intravenous Immunoglobulin (IV Ig) alone
- C. Mechanical Ventilation alone
- D. Plasmapheresis
Treatment Planning Process Explanation: ***Intravenous Immunoglobulin (IV Ig) and Plasmapheresis***
- Both **IV Ig** and **plasmapheresis** are equally effective first-line disease-modifying treatments for GBS in children
- **IV Ig** works by neutralizing pathogenic antibodies and modulating the immune response
- **Plasmapheresis** removes circulating antibodies and inflammatory mediators from the plasma
- Both treatments reduce the severity and duration of paralysis and accelerate recovery
- They are equally effective with **no significant difference in outcomes**; choice depends on availability, contraindications, and patient factors
*Intravenous Immunoglobulin (IV Ig) alone*
- While IV Ig is indeed a first-line treatment, it is not the only one
- The question asks for treatments (plural), and plasmapheresis is equally effective
*Mechanical Ventilation alone*
- This is a **supportive measure** for respiratory failure, not a disease-modifying treatment
- About 20-30% of GBS patients require mechanical ventilation due to respiratory muscle weakness
- It manages complications but does not treat the underlying immune-mediated neuropathy
*Plasmapheresis alone*
- While plasmapheresis is indeed a first-line treatment, it is not the only one
- The question asks for treatments (plural), and IV Ig is equally effective
Treatment Planning Process Indian Medical PG Question 8: Which of the following statements is incorrect regarding the strategic plan for malaria control 2012-2017?
- A. 50% reduction in mortality by 2017
- B. Objective is API < 1 per 10,000 (Correct Answer)
- C. Complete treatment to 100% of patients
- D. Annual incidence < 1 per 1000 by 2017
Treatment Planning Process Explanation: ***Objective is API < 1 per 10,000***
- The correct objective for the **Annual Parasite Incidence (API)** in the 2012-2017 strategic plan for malaria control was to reduce it to **less than 1 per 1,000 population**, not 1 per 10,000, making this statement incorrect.
- This metric measures the number of new malaria cases per 1,000 people per year.
*50% reduction in mortality by 2017*
- A key objective of the **National Framework for Malaria Elimination in India** (which this strategic plan aimed to contribute to) was indeed to achieve a significant reduction in malaria-related mortality.
- Specifically, aiming for a **50% reduction in mortality** by 2017 was a stated goal to lessen the disease burden.
*Annual incidence < 1 per 1000 by 2017*
- One of the primary goals of the **Malaria Control Strategic Plan 2012-2017** was to reduce the annual parasite incidence (API) to **less than 1 per 1,000 population** in all endemic areas.
- This target focused on decreasing the occurrence of new malaria cases.
*Complete treatment to 100% of patients*
- A core component of malaria control strategies emphasizes ensuring that **all confirmed malaria cases** receive complete and effective treatment.
- Achieving **100% complete treatment adherence** is crucial to prevent drug resistance and eliminate the parasite reservoir.
Treatment Planning Process Indian Medical PG Question 9: India is a country with different cultures and diverse languages. Which steps should a physician take to address the patient for better outcomes?
1. Insist on good communication
2. Insist on communication only via an interpreter
3. Treat them regardless of their cultural perceptions
4. The physician should consider the patient's religion and cultural perception
Select the correct combination:
- A. 1,4 (Correct Answer)
- B. 1,2
- C. 2,3
- D. 3,4
Treatment Planning Process Explanation: ***1,4***
- **Good communication** is paramount in healthcare, especially in a diverse country like India, to ensure **patient understanding**, **adherence** to treatment plans, and overall patient satisfaction.
- Considering a patient's **religion and cultural perceptions** allows the physician to tailor treatment and communication in a sensitive and **respectful manner**, fostering trust and better **health outcomes**.
*1,2*
- While good communication (1) is vital, **insisting solely on an interpreter** (2) may not always be feasible or necessary, particularly if the physician and patient share a common language or if the patient prefers direct communication. This can also disrupt the flow of rapport building.
- **Over-reliance on interpreters** can sometimes lead to misinterpretations or loss of non-verbal cues if the interpreter is not trained in medical interpretation.
*2,3*
- **Insisting only on an interpreter** (2) can be restrictive and may compromise direct patient-physician rapport, as discussed above.
- **Treating patients regardless of their cultural perceptions** (3) is an ethnocentric approach that can lead to mistrust, non-adherence, and ultimately **poor health outcomes** as it disregards the patient's beliefs and values regarding health and illness.
*3,4*
- **Treating patients regardless of their cultural perceptions** (3) can result in a lack of understanding and non-adherence if the treatment conflicts with the patient's deeply held beliefs.
- While considering religion and cultural perception (4) is crucial, this option includes an incorrect approach (3) that can undermine patient care.
Treatment Planning Process Indian Medical PG Question 10: Which radiotherapy technique involves the use of remote afterloading to deliver radiation directly to the tumor?
- A. Brachytherapy (Correct Answer)
- B. External Beam Radiotherapy
- C. Stereotactic Radiotherapy
- D. Proton Beam Radiotherapy
Treatment Planning Process Explanation: ***Correct: Brachytherapy***
- **Remote afterloading** is a hallmark of modern brachytherapy, where radioactive sources are automatically advanced into catheters placed within or near the tumor.
- This technique allows for the delivery of a **high dose of radiation directly to the tumor** while sparing surrounding healthy tissues.
- Examples include **intracavitary** (cervical cancer), **interstitial** (prostate cancer), and **intraluminal** (esophageal cancer) brachytherapy.
*Incorrect: External Beam Radiotherapy*
- This technique involves delivering radiation from a machine **outside the body** to target a tumor.
- It does not involve the direct placement of radioactive sources within the patient or the use of **remote afterloading**.
*Incorrect: Stereotactic Radiotherapy*
- While a precise form of external beam radiotherapy using focused beams, it still involves an **external source** of radiation.
- It does not utilize internal radioactive sources or **afterloading techniques**.
*Incorrect: Proton Beam Radiotherapy*
- This is an advanced form of external beam radiotherapy that uses **protons instead of photons** to deliver radiation with high precision.
- It does not involve the placement of radioactive sources within the patient or the use of **remote afterloading**.
More Treatment Planning Process Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
